Related Experiment Video
Updated: Jun 3, 2026
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Synthesis and biological evaluation of novel acenaphthene derivatives as potential antitumor agents
Yong-Mei Xie1, Yi Deng, Xiao-Yun Dai
1State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
Abstract:
Twelve novel acenaphthene derivatives have been synthesized. The structures of all compounds were confirmed by ¹H-NMR, MS and elemental analysis. Their antitumor activities were evaluated in six human solid tumor cell lines, namely non-small cell lung cancer (H460), human colon adenocarcinoma (SW480), human breast cancer cell (MDA-MB-468 and SKRB-3), human melanoma cell (A375) and human pancreatic cancer (BxPC-3). Among them, compound 3c shows the best antitumor activity against SKRB-3 cell line, as high as the positive control adriamycin.
Insights
Researchers synthesized novel acenaphthene derivatives and tested their antitumor properties. Compound 3c demonstrated significant anticancer activity against human breast cancer cells, comparable to adriamycin.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Research
Background:
- Acenaphthene derivatives are a class of organic compounds with potential biological activities.
- Developing novel anticancer agents is crucial for combating various human solid tumors.
Purpose of the Study:
- To synthesize and characterize novel acenaphthene derivatives.
- To evaluate the in vitro antitumor activity of these synthesized compounds against a panel of human solid tumor cell lines.
Main Methods:
- Synthesis of twelve novel acenaphthene derivatives.
- Structural confirmation using spectroscopic techniques (¹H-NMR, MS) and elemental analysis.
- In vitro cytotoxicity assays against six human cancer cell lines (H460, SW480, MDA-MB-468, SKRB-3, A375, BxPC-3).
Main Results:
- All twelve synthesized acenaphthene derivatives were successfully characterized.
- Compound 3c exhibited potent antitumor activity against the SKRB-3 (human breast cancer) cell line.
- The activity of compound 3c was comparable to the positive control, adriamycin.
Conclusions:
- Novel acenaphthene derivatives were synthesized and their structures confirmed.
- Compound 3c is a promising candidate for further investigation as an anticancer agent, particularly for breast cancer.
- The study highlights the potential of acenaphthene scaffolds in the development of new chemotherapeutic drugs.
